In The News
YOKNEAM, Israel, March 19, 2020 — ChroniSense Medical, developer of Polso™, a wearable, medical-grade, disease management device for multiple clinical applications, announced the appointment of Bridget Ross as Chief Executive Officer (CEO) effective February 10, 2020.
Supira Medical, A Shifamed Portfolio Company, Closes $35M in Series B Financing; Company Appoints Seasoned Medtech Executive as President and CEO
CAMPBELL, Calif., March 5, 2020 – Supira Medical, formed by Shifamed as part of its medical innovation hub, announced today the closing of $35M in Series B financing. Officially closed on February 25, the financing was led by Cormorant Asset Management with participation from The Capital Partnership (TCP), 415 CAPITAL, AMED Ventures and Shifamed Angels. The funds will be used to advance product development and clinical efforts for the company’s next generation percutaneous ventricular assist device (pVAD). Additionally, the company announced the appointment of seasoned medical device executive, Dr. Nitin Salunke, as President and Chief Executive Officer.
one80⁰’s Recent Placements
one80⁰ is pleased to announce several of our most recent placements:
- Nitin Salunke – CEO, Supira Medical
- Bridget Ross – CEO, ChroniSense Medical
- Kristi Dahlke – CFO, GI Supply
- Eleanor Dominguez – VP, Marketing, CAN Mobilities
We look forward to watching the continued growth and success of these companies!
one80⁰’s 2019 Midyear Placements
one80⁰ has had the pleasure of working with a number of exceptional clients and candidates in the first half of 2019. A few of our placements include:
- Kate Rumrill – CEO, Ablative Solutions
- Av Edidin – SVP, Development & Manufacturing, Procyrion
- Lisa Holt – SVP, Clinical & Medical Affairs, Metavention
- Stephen Rempe – VP, Human Resources, Cardiovascular Systems, Inc.
- Patrick Lyon – VP, Marketing, Relievant Medsystems
We wish them all continued success!
SAN JOSE, Calif.–(BUSINESS WIRE)– Ablative Solutions Inc., a company pioneering new approaches to the treatment of hypertension, today announced that Kate Rumrill has been appointed as the new President and CEO. Rumrill will also serve on the board of directors for the company. With 30 years industry experience, Rumrill brings deep expertise in delivering products to market from both the pharmaceutical and medical device industries.
SAN FRANCISCO, June 27, 2018 (GLOBE NEWSWIRE) – iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital health care solutions company focused on the advancement of cardiac care, announced today the appointment of Karim Karti to Chief Operating Officer effective July 23, 2018. Karti brings more than 20 years of experience and a proven track record of driving growth, profitability and innovation in the global health care technology and services industry…
WALTHAM, Mass.–(BUSINESS WIRE)–Avedro, Inc., an ophthalmic pharmaceutical and medical device company and the world leader in corneal remodeling, today announced that James F. Schuermann has joined the company as Chief Business Officer (CBO). Mr. Schuermann will lead the global government affairs, health economics and reimbursement, communications, sales, field service, marketing and business development functions and will report to Avedro’s Chief Executive Officer, Reza Zadno…
SUNNYVALE, Calif., March 06, 2018 (GLOBE NEWSWIRE) — Relievant Medsystems, a privately held medical device company that has developed the Intracept® Procedure, a minimally invasive and clinically proven approach for the treatment of chronic low back pain, announced today the appointment of Christopher Geyen as Chief Financial Officer. Mr. Geyen will report to Relievant’s Chief Executive Officer, Kevin Hykes.
Procyrion Names Elisabeth Neely Senior Vice President of Clinical and Regulatory Affairs, Formerly with Abbott
Houston, Texas (March 21, 2018) – Procyrion, Inc., a clinical-stage medical device company developing the first catheter-deployed, intra-aortic pump for ambulatory use, AortixTM, today announced the appointment of Elisabeth (Beth) Neely, RAC, as Senior Vice President of Clinical and Regulatory Affairs. In this role, Neely will proactively develop, lead and drive the execution of a global regulatory and clinical strategy with a focus on efficient, rapid and timely approval of the novel Aortix device…
Respicardia Announces First U.S. Commercial Case with the remedē® System; Industry Veteran Peter Sommerness Joins as CEO to Lead U.S. Launch
MINNETONKA, Minn., Feb. 2, 2018 /PRNewswire/ — Respicardia, Inc., a medical technology company developing innovative therapies that improve cardiovascular health, announced today that the first U.S. commercial case using the remedē® System to treat central sleep apnea was completed at The Ohio State University Wexner Medical Center in Columbus, Ohio by Ralph Augostini, MD, FACC, FHRS, Bob and Corrine Frick Chair in Cardiac Electrophysiology, Associate Professor of Medicine and co-director of the electrophysiology training program. The first case coincides with the naming of season medical device executive, Peter Sommerness, as CEO of Respicardia and the leader of the remedē® system U.S. launch…
DURHAM, N.C.–(BUSINESS WIRE)–Tryton Medical, Inc., the leading developer of stents designed to definitively treat bifurcation lesions, today announced that the company has appointed Carl J. St. Bernard as president and chief executive officer…
MOUNTAIN VIEW, Calif., Dec. 04, 2017 (GLOBE NEWSWIRE) — Vascular Dynamics, Inc. (VDI), a privately held medical device company which has developed an innovative treatment system for the treatment of hypertension, today announced the appointment of Mr. Ed Roschak as its president and chief executive officer…